EA201900478A1 - METHOD FOR TREATING INFLAMMATORY PROCESSES OF JOINT AND PROSTATITIS - Google Patents

METHOD FOR TREATING INFLAMMATORY PROCESSES OF JOINT AND PROSTATITIS

Info

Publication number
EA201900478A1
EA201900478A1 EA201900478A EA201900478A EA201900478A1 EA 201900478 A1 EA201900478 A1 EA 201900478A1 EA 201900478 A EA201900478 A EA 201900478A EA 201900478 A EA201900478 A EA 201900478A EA 201900478 A1 EA201900478 A1 EA 201900478A1
Authority
EA
Eurasian Patent Office
Prior art keywords
inflammatory processes
injection
carried out
treatment
protein
Prior art date
Application number
EA201900478A
Other languages
Russian (ru)
Inventor
Александр Владимирович ИЛЬИЧЁВ
Дмитрий Григорьевич МАЛЬДОВ
Сергей Иванович Прокопович
Original Assignee
Закрытое акционерное общество "СКАЙ ЛТД"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Закрытое акционерное общество "СКАЙ ЛТД" filed Critical Закрытое акционерное общество "СКАЙ ЛТД"
Publication of EA201900478A1 publication Critical patent/EA201900478A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/44—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests having means for cooling or heating the devices or media
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rheumatology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Изобретение относится к области медицины, в частности для консервативного лечения различных воспалительных процессов, таких как радикулит, артрит, артроз, подагра, остеохондроз и др. Способ лечения воспалительных процессов осуществляют путём внутримышечной инъекции препаратом на основе биологически активного компонента. Согласно изобретению инъекцию осуществляют комплексом сывороточного альбумина, выделенного из фолликулярной жидкости крупного рогатого скота и белка семейства TGF, дозой на одну инъекцию от 150 до 400 мг общего белка. Курс лечения включает от 5 до 10 инъекций по 1 инъекции ежедневно. Лечение, в зависимости от тяжести заболевания, осуществляют курсами от 1 до 5 с перерывами между курсами один месяц. В качестве препарата на основе комплекса сывороточного альбумина, выделенного из фолликулярной жидкости крупного рогатого скота и белка семейства TGF, используют Эндоферин. Техническими результатами изобретения являются повышение терапевтического эффекта в практике лечения ряда заболеваний, обусловленных воспалительными процессами, без побочных проявлений, а также расширение арсенала медикаментозных средств для консервативного лечения.The invention relates to medicine, in particular for the conservative treatment of various inflammatory processes, such as radiculitis, arthritis, arthrosis, gout, osteochondrosis, etc. A method of treating inflammatory processes is carried out by intramuscular injection with a drug based on a biologically active component. According to the invention, the injection is carried out with a complex of serum albumin isolated from cattle follicular fluid and a protein of the TGF family, with a dose of 150 to 400 mg of total protein per injection. The course of treatment includes from 5 to 10 injections, 1 injection daily. Treatment, depending on the severity of the disease, is carried out in courses from 1 to 5 with breaks between courses of one month. Endoferin is used as a preparation based on a complex of serum albumin isolated from cattle follicular fluid and a protein of the TGF family. The technical results of the invention are to increase the therapeutic effect in the practice of treating a number of diseases caused by inflammatory processes without side effects, as well as expanding the arsenal of medications for conservative treatment.

EA201900478A 2018-12-04 2019-10-16 METHOD FOR TREATING INFLAMMATORY PROCESSES OF JOINT AND PROSTATITIS EA201900478A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2018142642A RU2703257C1 (en) 2018-12-04 2018-12-04 Method of treating inflammatory processes of joints and prostatitis

Publications (1)

Publication Number Publication Date
EA201900478A1 true EA201900478A1 (en) 2020-06-30

Family

ID=68280106

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201900478A EA201900478A1 (en) 2018-12-04 2019-10-16 METHOD FOR TREATING INFLAMMATORY PROCESSES OF JOINT AND PROSTATITIS

Country Status (2)

Country Link
EA (1) EA201900478A1 (en)
RU (1) RU2703257C1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2104000C1 (en) * 1994-06-30 1998-02-10 Борис Иванович Блескин Method of treatment of inflammatory processes
US6515016B2 (en) * 1996-12-02 2003-02-04 Angiotech Pharmaceuticals, Inc. Composition and methods of paclitaxel for treating psoriasis
UA111162C2 (en) * 2010-08-04 2016-04-11 Флекшен Терап'Ютікс, Інк. INJECTION COMPOSITION OF TRIAMCINOLONE ACETONIDE FOR TREATMENT OF PAIN
RU2660587C1 (en) * 2017-09-19 2018-07-06 Федеральное государственное бюджетное учреждение науки Институт биологии развития им. Н.К. Кольцова РАН (ИБР РАН) Protein-peptide complex increasing the viability of follicules in mammal ovarians

Also Published As

Publication number Publication date
RU2703257C1 (en) 2019-10-16

Similar Documents

Publication Publication Date Title
Mamik et al. Inflammasomes in neurological diseases: emerging pathogenic and therapeutic concepts
Sun et al. Neuroprotection by IFN-γ via astrocyte-secreted IL-6 in acute neuroinflammation
Chatterjea et al. Mast cells: versatile gatekeepers of pain
Hansen et al. Human Stiff person syndrome IgG-containing high-titer anti-GAD65 autoantibodies induce motor dysfunction in rats
Afrin et al. Mast cell activation disease: an underappreciated cause of neurologic and psychiatric symptoms and diseases
Lora et al. Botulinum toxin type A reduces inflammatory hypernociception induced by arthritis in the temporomadibular joint of rats
AR095614A1 (en) BISPS SPECIFIC HETERODIMERIC ANTIBODIES
Medvedeva et al. The peptide semax affects the expression of genes related to the immune and vascular systems in rat brain focal ischemia: genome-wide transcriptional analysis
AR085281A1 (en) MODULATORS OF PROTEIN THYROSINE KINASE 7 (PTK7) AND METHODS FOR USE
RU2018102103A (en) THERAPY AND DIAGNOSTICS BASED ON PROTEINS OF TAU-MEDIATED PATHOLOGY IN ALZHEIMER'S DISEASE
BRPI0615297A2 (en) il-23 and il-17 antagonists to treat autoimmune inflammatory eye disease and their uses
DE69932084D1 (en) Antibody fragments for the local treatment of eye diseases
HRP20230992T1 (en) Methods for treating or preventing atherosclerosis by administering an inhibitor of angptl3
Meier et al. The kynurenine pathway in traumatic brain injury: Implications for psychiatric outcomes
AU2015355150A1 (en) Methods for treating dry eye disease by administering an IL-6R antagonist
JP2019521156A5 (en)
US20230331834A1 (en) Method of treating tendinopathy using interleukin-17 (il-17)
KR20080080079A (en) Chaperonin 10-induced immunomodulation
RU2018145017A (en) APPLICATION OF SIROLIMUS FOR TREATMENT OF EXUDATIVE AGE-RELATED MACULAR DEGENERATION WITH PERSISTENT Edema
EA201900478A1 (en) METHOD FOR TREATING INFLAMMATORY PROCESSES OF JOINT AND PROSTATITIS
AR122129A1 (en) TAU VACCINE FOR THE TREATMENT OF ALZHEIMER'S DISEASE
Barbier et al. The claustrum is a target for projections from the supramammillary nucleus in the rat
Leong et al. Potent neurotoxins for cancer pain treatment: resiniferatoxin and saporin
EA202190724A1 (en) KETAMINE-BASED PREPARATION FOR TREATMENT OF DEPRESSION BY INHALATION
EP2803364A1 (en) Pharmaceutical combined preparation with an anti-idiotypic antibody fragment